RESUMEN
Locally advanced breast cancer (LABC) is a heterogeneous group of breast cancer that accounts for 10-30% of breast cancer cases. Despite the ongoing development of current treatment methods, LABC remains a severe and complex public health concern around the world, thus prompting the urgent requirement for innovative diagnosis and treatment strategies. The primary treatment challenges are inoperable clinical status and ineffective local control methods. With the rapid advancement of nanotechnology, inorganic nanoparticles (INPs) exhibit a potential application prospect in diagnosing and treating breast cancer. Due to the unique inherent characteristics of INPs, different functions can be performed via appropriate modifications and constructions, thus making them suitable for different imaging technology strategies and treatment schemes. INPs can improve the efficacy of conventional local radiotherapy treatment. In the face of inoperable LABC, INPs have proposed new local therapeutic methods and fostered the evolution of novel strategies such as photothermal and photodynamic therapy, magnetothermal therapy, sonodynamic therapy, and multifunctional inorganic nanoplatform. This article reviews the advances of INPs in local accurate imaging and breast cancer treatment and offers insights to overcome the existing clinical difficulties in LABC management.
Asunto(s)
Neoplasias de la Mama , Humanos , Neoplasias de la Mama/terapia , Femenino , Nanoestructuras/uso terapéutico , Nanoestructuras/química , Nanopartículas/química , Nanopartículas/uso terapéutico , Animales , Fotoquimioterapia/métodos , Compuestos Inorgánicos/químicaRESUMEN
Cr(VI) is a toxic, teratogenic, and carcinogenic heavy metal element in soil that poses major ecological and human health risks. In this study, microcosm tests combined with X-ray absorption near-edge spectra (XANES) and 16Sr DNA amplification techniques were used to explore the effect of Ginkgo biloba leaves on the removal efficiency of Cr(VI) in soil and its underlying mechanism. Ginkgo biloba leaves had a favorable remediation effect on soil varying in Cr(VI) contamination levels, and the optimal effect was observed when 5% Ginkgo biloba leaves were added. The occurrence state of Cr(VI) in soil before and after the addition of Ginkgo biloba leaves was analyzed by XANES, which revealed that Cr(VI) was fully converted to the more biologically innocuous Cr(III), and the hydroxyl-containing quercetin in Ginkgo biloba leaves was one of the primary components mediating this reduction reaction. The Cr(VI) content was significantly lower in non-sterilized soil than in sterilized soil, suggesting that soil microorganisms play a key role in the remediation process. The addition of Ginkgo biloba leaves decreased the α-diversity and altered the ß-diversity of the soil bacterial community. Actinobacteria was the dominant phylum in the soil remediated by Ginkgo biloba leaves; four genera of Cr(VI)-reducing bacteria were also enriched, including Agrococcus, Klebsiella, Streptomyces, and Microbacterium. Functional gene abundances predicted by PICRUST indicated that the expression of glutathione synthesis genes was substantially up-regulated, which might be the main metabolic pathway underlying the mitigation of Cr(VI) toxicity in soil by Cr(VI)-reducing bacteria. In sum, Ginkgo biloba leaves can effectively remove soil Cr(VI) and reduce Cr(VI) to Cr(III) via quercetin in soil, which also functions as a carbon source to drive the production of glutathione via Cr(VI)-reducing bacteria and mitigate Cr(VI) toxicity. The findings of this study elucidate the chemical and microbial mechanisms of Cr(VI) removal in soil by Ginkgo biloba leaves and provide insights that could be used to enhance the remediation of Cr(VI)-contaminated soil.
Asunto(s)
Ginkgo biloba , Contaminantes del Suelo , Humanos , Ginkgo biloba/química , Suelo/química , Quercetina , Cromo/análisis , Glutatión , Contaminantes del Suelo/análisisRESUMEN
In cross-border transactions, the transmission and processing of logistics information directly affect the trading experience and efficiency. The use of Internet of Things (IoT) technology can make this process more intelligent, efficient, and secure. However, most traditional IoT logistics systems are provided by a single logistics company. These independent systems need to withstand high computing loads and network bandwidth when processing large-scale data. Additionally, due to the complex network environment of cross-border transactions, the platform's information security and system security are difficult to guarantee. To address these challenges, this paper designs and implements an intelligent cross-border logistics system platform that combines serverless architecture and microservice technology. This system can uniformly distribute the services of all logistics companies and divide microservices based on actual business needs. It also studies and designs corresponding Application Programming Interface (API) gateways to solve the interface exposure problem of microservices, thereby ensuring the system's security. Furthermore, asymmetric encryption technology is used in the serverless architecture to ensure the security of cross-border logistics data. The experiments show that this research solution validates the advantages of combining serverless architecture and microservices, which can significantly reduce the operating costs and system complexity of the platform in cross-border logistics scenarios. It allows for resource expansion and billing based on application program requirements at runtime. The platform can effectively improve the security of cross-border logistics service processes and meet cross-border transaction needs in terms of data security, throughput, and latency.
RESUMEN
H1N1 influenza has brought serious threats to people's health and a high socioeconomic burden to society. Oseltamivir, a kind of neuraminidase (NA) inhibitor, is the second-generation specific drug that is broadly used currently. However, H1N1 influenza viruses have exhibited oseltamivir resistance in the past decades, which might be a hidden danger. To understand the frequency and distribution laws of oseltamivir-resistant viruses, we conducted a thorough and deep analysis of the available NA protein sequences of H1N1 influenza viruses worldwide from 1918 to 2020. The differences and similarities before and after 2009 were also considered since the dominant viruses changed in this period. Results showed that 3.76% of H1N1 viruses harbored oseltamivir resistance currently. Among various significative mutations, H274Y had the highest frequency of 3.30%, while the frequencies of the other mutations were far below this whether before or after 2009. The oseltamivir resistance was mainly found in three hosts, humans, swine, and avian. Different mutation sites could exhibit different distributions in each host. Our results showed that the resistance level reached a peak during the 2007-2008 influenza season and then quickly decreased in 2009. The resistance also displayed a global distribution. The densely populated countries usually had a high resistance level. However, frequent significative mutations were also found in some small countries. Our findings indicated the necessity of monitoring oseltamivir resistance around the world. The study could provide a unique perspective toward the cognition of viruses and facilitate the future study of both pandemic and drug development.
Asunto(s)
Farmacorresistencia Viral , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana , Oseltamivir , Animales , Antivirales/farmacología , Antivirales/uso terapéutico , Farmacorresistencia Viral/genética , Humanos , Subtipo H1N1 del Virus de la Influenza A/genética , Gripe Humana/tratamiento farmacológico , Gripe Humana/epidemiología , Mutación , Neuraminidasa/antagonistas & inhibidores , Neuraminidasa/genética , Oseltamivir/farmacología , Oseltamivir/uso terapéutico , Porcinos , Proteínas Virales/genéticaRESUMEN
H1N1 influenza is a kind of acute respiratory infectious disease that has a high socioeconomic and medical burden each year around the world. In the past decades, H1N1 influenza viruses have exhibited high resistance to adamantanes, which has become a serious issue. To understand the up-to-date distribution and evolution of H1N1 influenza viruses with adamantanes-resistant mutations, we conducted a deep analysis of 15875 M2 protein and 8351 MP nucleotides sequences. Results of the distribution analyses showed that 77.32% of H1N1 influenza viruses harbored-resistance mutations of which 73.52% were S31N, And the mutant variants mainly appeared in North America and Europe and H1N1 influenza viruses with S31N mutation became the circulating strains since 2009 all over the world. In addition, 80.65% of human H1N1 influenza viruses and 74.61% of swine H1N1 influenza viruses exhibited adamantanes resistance, while the frequency was only 1.86% in avian H1N1 influenza viruses. Studies from evolutionary analyses indicated that the avian-origin swine H1N1 influenza viruses replaced the classical human H1N1 influenza viruses and became the circulating strains after 2009; The interspecies transmission among avian, swine, and human strains over the past 20 years contributed to the 2009 swine influenza pandemic. Results of our study clearly clarify the historical drug resistance level of H1N1 influenza viruses around the world and demonstrated the evolution of adamantanes-resistant mutations in H1N1 influenza viruses. Our findings emphasize the necessity for monitoring the adamantanes susceptibility of H1N1 influenza viruses and draw attention to analyses of the evolution of drug-resistant H1N1 influenza variants.
Asunto(s)
Adamantano/farmacología , Antivirales/farmacología , Farmacorresistencia Viral/genética , Evolución Molecular , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Subtipo H1N1 del Virus de la Influenza A/genética , Mutación , Animales , Europa (Continente) , Especificidad del Huésped , Humanos , Subtipo H1N1 del Virus de la Influenza A/clasificación , Gripe Humana/virología , América del Norte , Infecciones por Orthomyxoviridae/virología , Filogenia , Porcinos , Proteínas Virales/genéticaRESUMEN
A cross-priming isothermal amplification (CPA) assay was developed for detection of feline herpesvirus type 1 (FHV-1). In this assay, the target fragment of the FHV-1 glycoprotein B gene is amplified rapidly by Bst DNA polymerase at a constant temperature (63 °C, 45 min), using a simple thermostat. The assay had no cross-reactions with four types of feline viruses, and the detection limit was 100 copies/µl. The positive rate of clinical samples from CPA was 100% consistent with qPCR but higher than ordinary PCR, indicating its superiority to ordinary PCR. Visualization was achieved using SYBR Green I dye.
Asunto(s)
Enfermedades de los Gatos/virología , Reactividad Cruzada , Técnicas de Amplificación de Ácido Nucleico/veterinaria , Varicellovirus/aislamiento & purificación , Proteínas del Envoltorio Viral/aislamiento & purificación , Animales , Enfermedades de los Gatos/diagnóstico , Gatos , Cartilla de ADN/genética , Técnicas de Amplificación de Ácido Nucleico/economía , Técnicas de Amplificación de Ácido Nucleico/métodos , Sensibilidad y EspecificidadRESUMEN
Glioma is one of the most serious central nervous system diseases, with high mortality and poor prognosis. Despite the continuous development of existing treatment methods, the median survival time of glioma patients is still only 15 months. The main treatment difficulties are the invasive growth of glioma and the obstruction of the blood-brain barrier (BBB) to drugs. With rapid advancements in nanotechnology, inorganic nanoparticles (INPs) have shown favourable application prospects in the diagnosis and treatment of glioma. Due to their extraordinary intrinsic features, INPs can be easily fabricated, while doping with other elements and surface modification by biological ligands can be used to enhance BBB penetration, targeted delivery and biocompatibility. Guided glioma theranostics with INPs can improve and enhance the efficacy of traditional methods such as chemotherapy, radiotherapy and gene therapy. New strategies, such as immunotherapy, photothermal and photodynamic therapy, magnetic hyperthermia therapy, and multifunctional inorganic nanoplatforms, have also been facilitated by INPs. This review emphasizes the current state of research and clinical applications of INPs, including glioma targeting and BBB penetration enhancement methods, in vivo and in vitro biocompatibility, and diagnostic and treatment strategies. As such, it provides insights for the development of novel glioma treatment strategies.
RESUMEN
In this study, we investigated the blending of poly(l-lactide) (PLLA) with supramolecular polymers based on poly(d-lactide)-poly(ε-caprolactone-co-δ-valerolactone)-poly(d-lactide) (PDLA-PCVL-PDLA) triblock copolymers as an efficient way to modify PLLA. The supramolecular polymers (SMP) were synthesized by the terminal functionalization of the PDLA-PCVL-PDLA copolymers with 2-ureido-4[1H]-pyrimidinone (UPy). The structure, thermal properties and rheological behavior of the synthesized supramolecular polymers were studied; we found that the formation of the UPy dimers expanded the molecular chain of the polymer and the incorporation of the UPy groups suppressed the crystallization of polymers. In addition, the synthesized supramolecular polymers had a low glass transition temperature of about -50 °C, showing the characteristics of elastomers. On this basis, superior properties such as a fast crystallization rate, high melt strength, and toughness of fully bio-based, i.e., PLA-based materials were achieved simultaneously by blending PLLA with the synthesized supramolecular polymers. In the PLLA/SMP blends, PLLA could form a stereocomplex with its enantiomeric PDLA blocks of supramolecular polymers, and the stereocomplex crystals with the cross-linking networks reinforced the melt strength of the PLLA/SMP blends. The influences of the SMP composition and the SMP content in the PLLA matrix on crystallization and mechanical properties were analyzed. The supramolecular polymers SMP0.49 and SMP1.04 showed a reverse effect on the crystallization of PLLA. Tensile tests revealed that the lower content of the synthesized supramolecular polymers could achieve toughening of the PLLA matrix. Therefore, the introduction of supramolecular polymers based on PDLA-PCVL-PDLA is an effective way to control the crystallization, rheology and mechanical properties of PLLA.